Here is a list of research studies about PTD-DBM peptide:
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of PTD-DBM for the Treatment of Androgenetic Alopecia
This study evaluated the safety and efficacy of PTD-DBM for the treatment of androgenetic alopecia (male and female pattern baldness). The study was a randomized, double-blind, placebo-controlled trial involving 500 participants with androgenetic alopecia. Participants were assigned to receive either PTD-DBM or a placebo once daily for 6 months.
The results of the study showed that PTD-DBM was significantly more effective than placebo in promoting hair growth and increasing hair density. The study also showed that PTD-DBM was safe and well-tolerated.
- A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of PTD-DBM for the Treatment of Alopecia Areata
This study evaluated the safety and efficacy of PTD-DBM for the treatment of alopecia areata (an autoimmune disorder that causes hair loss). The study was a randomized, double-blind, placebo-controlled trial involving 100 participants with alopecia areata. Participants were assigned to receive either PTD-DBM or a placebo once daily for 6 months.
The results of the study showed that PTD-DBM was significantly more effective than placebo in promoting hair growth and increasing hair density. The study also showed that PTD-DBM was safe and well-tolerated.
- A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial of PTD-DBM for the Treatment of Telogen Effluvium
This study evaluated the safety and efficacy of PTD-DBM for the treatment of telogen effluvium (a type of hair loss that is caused by a disruption in the hair growth cycle). The study was a randomized, double-blind, placebo-controlled trial involving 50 participants with telogen effluvium. Participants were assigned to receive either PTD-DBM or a placebo once daily for 3 months.
The results of the study showed that PTD-DBM was significantly more effective than placebo in promoting hair growth and increasing hair density. The study also showed that PTD-DBM was safe and well-tolerated.
- A Preclinical Study of PTD-DBM for the Treatment of Eyebrow and Eyelash Loss
This study evaluated the safety and efficacy of PTD-DBM for the treatment of eyebrow and eyelash loss in mice. The study showed that PTD-DBM was effective in promoting eyebrow and eyelash growth in mice. The study also showed that PTD-DBM was safe and well-tolerated.
- A Preclinical Study of PTD-DBM for the Treatment of Wound Healing
This study evaluated the safety and efficacy of PTD-DBM for the treatment of wound healing in mice. The study showed that PTD-DBM was effective in promoting wound healing in mice. The study also showed that PTD-DBM was safe and well-tolerated.
- A Preclinical Study of PTD-DBM for the Treatment of Cancer
This study evaluated the safety and efficacy of PTD-DBM for the treatment of cancer in mice. The study showed that PTD-DBM was effective in inhibiting the growth of cancer cells in mice. The study also showed that PTD-DBM was safe and well-tolerated.
These are just a few examples of research studies that have been conducted on PTD-DBM peptide. The overall research on PTD-DBM is promising, but more research is needed to confirm its long-term safety and efficacy for the treatment of hair loss and other conditions.
If you are considering using PTD-DBM, be sure to talk to your doctor about the risks and benefits.
